Nancy Klimas

Immune markers in viral reactivation

(Immune Markers & Viruses Session)

Daniel Peterson

Antiviral treatment of patients with HHV-6, EBV & Enterovirus:

Case reports

(Clinician Forum Session)

Kenny de Meirleir

Antiviral treatment strategies in Chronic Fatigue Syndrome

(Clinician Forum Session)

José Montoya

Role of elevated antibody titers against HHV-6 and EBV

in predicting response to Valganciclovir

in patients with Chronic Fatigue Syndrome

(Clinician Forum Session)

John Chia

The role of Enteroviruses

in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

(Enterovirus Session)

Brigitte Huber

EBV and IFN-a activation of

the human endogenous retrovirus HERV-K18 and CFS

(EBV and Other Viruses Session)

Jose Montoya

A randomized, double-blind, placebo-controlled trial

on the use of Valganciclovir in patients with Chronic Fatigue Syndrome (CFS) and elevated HHV-6 and EBV antibodies

(HHV-6 and 7 in CNS Dysfunction)

Anthony Komaroff

Overview on HHV-6 and Chronic Fatigue Syndrome

(HHV-6 and 7 in CNS Dysfunction Session)

Dario Di Luca

Overview of HHV-7

(Overview Session)

Jonathan Kerr

Gene expression subtypes of Chronic Fatigue Syndrome (CFS)

(Microarray Studies Session)

Jonathan Kerr

Stress and parvovirus B-19 associated arthritis and chronic fatigue

(Parvovirus B-19 session)

Kazuhiro Kondo

Identification of novel HHV-6 latent protein associated with

mood disorders in CFS, depressive disorder, bipolar disorder

and HHV-6 encephalopathy

(HHV-6 and 7 in CNS Dysfunction Session)

Paolo Lusso

HHV-6 and the immune system:

Mechanisms of immunomodulation and immunosuppression

(Immunology, DIHS & Autoimmunity Session)

Claude Genain

HHV-6 causes inflammatory demyelination in non-human primates

(MS Session)